Literature DB >> 20062075

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.

K Yamaguchi1, M Mandai, T Oura, N Matsumura, J Hamanishi, T Baba, S Matsui, S K Murphy, I Konishi.   

Abstract

Ovarian clear cell carcinoma (OCCC) shows unique clinical features including an association with endometriosis and poor prognosis. We previously reported that the contents of endometriotic cysts, especially high concentrations of free iron, are a possible cause of OCCC carcinogenesis through iron-induced persistent oxidative stress. In this study, we conducted gene expression microarray analysis using 38 ovarian cancer cell lines and identified genes commonly expressed in both OCCC cell lines and clinical samples, which comprise an OCCC gene signature. The OCCC signature reproducibly predicts OCCC specimens in other microarray data sets, suggesting that this gene profile reflects the inherent biological characteristics of OCCC. The OCCC signature contains known markers of OCCC, such as hepatocyte nuclear factor-1beta (HNF-1beta) and versican (VCAN), and other genes that reflect oxidative stress. Expression of OCCC signature genes was induced by treatment of immortalized ovarian surface epithelial cells with the contents of endometriotic cysts, indicating that the OCCC signature is largely dependent on the tumor microenvironment. Induction of OCCC signature genes is at least in part epigenetically regulated, as we found hypomethylation of HNF-1beta and VCAN in OCCC cell lines. This genome-wide study indicates that the tumor microenvironment induces specific gene expression profiles that contribute to the development of distinct cancer subtypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20062075     DOI: 10.1038/onc.2009.470

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Epigenetic determinants of ovarian clear cell carcinoma biology.

Authors:  Ken Yamaguchi; Zhiqing Huang; Noriomi Matsumura; Masaki Mandai; Takako Okamoto; Tsukasa Baba; Ikuo Konishi; Andrew Berchuck; Susan K Murphy
Journal:  Int J Cancer       Date:  2014-01-14       Impact factor: 7.396

2.  GO-Module: functional synthesis and improved interpretation of Gene Ontology patterns.

Authors:  Xinan Yang; Jianrong Li; Younghee Lee; Yves A Lussier
Journal:  Bioinformatics       Date:  2011-03-17       Impact factor: 6.937

3.  Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.

Authors:  Erina Suzuki; Sabine Kajita; Hiroyuki Takahashi; Toshihide Matsumoto; Tomoko Tsuruta; Makoto Saegusa
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

4.  Identification of multiple pathways involved in the malignant transformation of endometriosis (Review).

Authors:  Yumi Higashiura; Hirotaka Kajihara; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

Review 5.  Clear cell carcinoma of ovary and uterus.

Authors:  Rosalind M Glasspool; Iain A McNeish
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 6.  Precision medicine for ovarian clear cell carcinoma based on gene alterations.

Authors:  Takafumi Kuroda; Takashi Kohno
Journal:  Int J Clin Oncol       Date:  2020-02-04       Impact factor: 3.402

Review 7.  Iron overload and altered iron metabolism in ovarian cancer.

Authors:  Stephanie Rockfield; Joseph Raffel; Radhe Mehta; Nabila Rehman; Meera Nanjundan
Journal:  Biol Chem       Date:  2017-08-28       Impact factor: 3.915

Review 8.  Epigenetics in ovarian cancer.

Authors:  Yanina Natanzon; Ellen L Goode; Julie M Cunningham
Journal:  Semin Cancer Biol       Date:  2017-08-03       Impact factor: 15.707

9.  Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Tsukasa Baba; Ken Yamaguchi; Yumiko Yoshioka; Ikuo Konishi
Journal:  Cancer Biol Ther       Date:  2013-10-21       Impact factor: 4.742

10.  Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

Authors:  Yasuhito Tanase; Yoshihiko Yamada; Hiroshi Shigetomi; Hirotaka Kajihara; Akira Oonogi; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2011-10-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.